Chitosan Scaffold Containing Periostin Enhances Sternum Bone Healing and Decreases Serum Level of TNF-α and IL-6 after Sternotomy in Rat
- 23 February 2022
- journal article
- research article
- Published by Springer Nature in Tissue Engineering and Regenerative Medicine
- Vol. 19 (4) , 839-852
Abstract
BACKGROUND: In the aftermath of bone injuries, such as cranium and sternum, bone wax (BW) is used to control bleeding from the bone surfaces during surgery. Made up of artificial substances, however, it is associated with many complications such as inflammation, increased risk for infection, and bone repair delay. We, therefore, in this study set out to design and evaluate a novel BW without the above-mentioned side-effects reported for other therapies. METHODS: The pastes (new BW(s)) were prepared in the laboratory and examined by MTT, MIC, MBC, and degradability tests. Then, 60 adult male Wistar rats, divided into six equal groups including chitosan (CT), CT-octacalcium phosphate (OCP), CT-periostin (Post), CT-OCP-Post, Control (Ctrl), and BW, underwent sternotomy surgery. Once the surgeries were completed, the bone repair was assessed radiologically and thereafter clinically in vivo and in vitro using CT-scan, H&E, ELISA, and qRT-PCR. RESULTS: All pastes displayed antibacterial properties and the CT-Post group had the highest cell viability compared to the control group. In contrast to the BW, CT-Post group demonstrated weight changes in the degradability test. In the CT-Post group, more number of osteocyte cells, high trabeculae percentage, and the least fibrous connective tissue were observed compared to other groups. Additionally, in comparison to the CT and Ctrl groups, higher alkaline phosphatase activity, as well as decreased level of serum tumor necrosis factor-α, interleukin-6, and OCN in the CT-Post group was evident. Finally, Runx2, OPG, and RANKL genes’ expression was significantly higher in the CT-Post group than in other groups. CONCLUSION: Our results provide insights into the desirability of pastes in terms of cellular viability, degradability, antibacterial properties, and surgical site restoration compared to the BW group. Besides, Periostin could enhance the osteogenic properties of bone tissue defect site.Keywords
Funding Information
- Tehran University of Medical Sciences and Health Services (97-01-30-37677)
- Iran National Science Foundation (97001870)
This publication has 47 references indexed in Scilit:
- Osteoporosis: now and the futureThe Lancet, 2011
- Antimicrobial properties of chitosan and mode of action: A state of the art reviewInternational Journal of Food Microbiology, 2010
- The Matricellular Protein Periostin Is Required for Sost Inhibition and the Anabolic Response to Mechanical Loading and Physical ActivityJournal of Biological Chemistry, 2009
- Periostin‐like‐factor in osteogenesisJournal of Cellular Physiology, 2008
- Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat modelJournal of Antimicrobial Chemotherapy, 2008
- Biomarkers of bone health and osteoporosis riskProceedings of the Nutrition Society, 2008
- Histologically verified bone wax (beeswax) granuloma after median sternotomy in 17 of 18 autopsy casesPathology, 2006
- IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiologyCytokine & Growth Factor Reviews, 2004
- Does liberal use of bone wax increase the risk of mediastinitis?Interactive CardioVascular and Thoracic Surgery, 2003
- Osteoporosis in men with a history of tibial fractureJournal of Bone and Mineral Research, 1994